Engineered T cells
US-12590136-B2 · Mar 31, 2026 · US
Medigene Immunotherapies Gmbh patents
Medigene Immunotherapies Gmbh holds 7 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 7 |
| Recent patents | 3 |
| First publication | Jan 3, 2019 |
| Latest publication | Mar 31, 2026 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Mage a4 t cell receptors
US-2025346648-A1 · Nov 13, 2025 · US
Mage A4 T cell receptors
US-12344654-B2 · Jul 1, 2025 · US
Generation of antigen-specific TCRs
US-11155589-B2 · Oct 26, 2021 · US
Dendritic cell composition
US-10882891-B2 · Jan 5, 2021 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Engineered T cells
US-12590136-B2 · Mar 31, 2026 · US
Mage a4 t cell receptors
US-2025346648-A1 · Nov 13, 2025 · US
Mage A4 T cell receptors
US-12344654-B2 · Jul 1, 2025 · US
Generation of antigen-specific TCRs
US-11155589-B2 · Oct 26, 2021 · US
Dendritic cell composition
US-10882891-B2 · Jan 5, 2021 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 7 |
| Chemistry & Metallurgy | 7 |
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Medigene Immunotherapies Gmbh have in patentsdb?
- Medigene Immunotherapies Gmbh is linked to 7 publications as assignee in our database.
- What technology areas does Medigene Immunotherapies Gmbh patent most?
- Top mapped technology areas by patent count: Human Necessities (7); Chemistry & Metallurgy (7).
- Is Medigene Immunotherapies Gmbh's patent activity growing?
- In our data, assignee counts were 2 in 2021 and 2 in 2025 (similar year over year).
- What are recent patents assigned to Medigene Immunotherapies Gmbh?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.